SCHEMBL16161505

SCHEMBL16161505

COc1cccc(-c2cnc(N)c3[nH]nc(Nc4ccccc4Cl)c23)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BTK Q06187 6/20 0.59
▸ ADORA2A P29274 1/20 0.47
▸ ADORA1 P30542 1/20 0.47
▸ PDGFRB P09619 1/20 0.41
▸ CLK1 P49759 2/20 0.40
▸ CDK5 Q00535 1/20 0.40
▸ CDK5R1 Q15078 1/20 0.40
▸ CYP1A2 P05177 2/20 0.40
▸ CYP3A4 P08684 2/20 0.40
▸ CYP2D6 P10635 2/20 0.40
▸ MAPK1 P28482 2/20 0.40
▸ CYP2C19 P33261 2/20 0.40
▸ HSD17B10 Q99714 1/20 0.40
▸ DHODH Q02127 1/20 0.39
▸ ABL1 P00519 1/20 0.39
▸ EGFR P00533 1/20 0.39
▸ CDK1 P06493 1/20 0.39
▸ SRC P12931 1/20 0.39
▸ ABL2 P42684 1/20 0.39
▸ MKNK1 Q9BUB5 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8402235 0.89 BTK (0.75) BTKADORA2AADORA1CLK1CDK5
SCHEMBL6115784 0.78 BTK (0.81) BTKADORA2AADORA1CYP1A2CYP3A4
SCHEMBL6115583 0.74 BTK (1.00) BTKADORA2AADORA1CYP1A2CYP3A4
SCHEMBL18800760 0.74 BTK (0.61) BTKADORA2AADORA1PDGFRBCLK1
SCHEMBL1162774 0.73 BTK (1.00) BTKADORA2AADORA1CLK1CYP1A2
SCHEMBL8402322 0.72 BTK (0.71) BTKADORA2AADORA1CLK1CDK5
SCHEMBL8402333 0.70 BTK (0.74) BTKADORA2AADORA1CYP1A2CYP3A4
SCHEMBL1163102 0.69 BTK (0.77) BTKADORA2AADORA1CYP1A2CYP3A4
SCHEMBL6115895 0.69 BTK (0.78) BTKPDGFRBDHODHMAPT
SCHEMBL6116666 0.68 ADORA2A (0.47) BTKADORA2AADORA1CLK1CDK5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2789615-A1 Azaindazoles as Btk kinase modulators and use thereof Bristol-Myers Squibb Company (US) 2014-10-15 — — EP claimed
Send feedback